Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

In breve

<article class="story default clearfix">

<h2> <a href="https://www.middleeasteye.net/news/israels-gaza-offshore-gas-plans-condemned-illegal-resource-grab" rel="bookmark"> <span class="field field-title">Israel’s Gaza offshore gas plans condemned as illegal resourc

Contesto

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial The interim Phase I trial data was only from 35 people, but results look good so far. According to the collected source material from feeds.arstechnica.com, The interim Phase I trial data was only from 35 people, but results look good so far. Editorial classification signals include category: cronaca ; source timestamp: 2026-05-28T13:39:49+00:00. This draft is a structured rewrite of the feed material and does not add unsupported facts. Its purpose is to provide a stronger editorial base for automated review and publication gating.

Lettura DEO

Verdetto: publish
Confidenza: 82/100

Deterministic fallback judge output. Libre judge fallback via DeepSeek Gamma.

Categoria: cronaca